Intimation of Investor Conference Call for Q4 & FY25 with Senior Management of Mankind Pharma Limited ( the Company )
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has scheduled an investor conference call on Wednesday, May 21, 2025 at 6:00 PM IST to discuss its Q4 and full-year FY25 business performance and results. The call is being announced under SEBI listing regulations, and dial-in numbers have been provided for both Indian and international participants (USA, UK, Singapore, Hong Kong). Senior management including Vice Chairman & MD Rajeev Juneja, CEO Sheetal Arora, COO Arjun Juneja, CMO Dr. Sanjay Koul, and Group CFO Ashutosh Dhawan will represent the company. The filing was made on May 12, 2025, about 9 days before the scheduled call.
This is a routine pre-earnings announcement that signals Q4 and FY25 results are imminent. Investors and analysts should watch the actual earnings release closely following the call on May 21 for revenue, margins, and growth guidance that could influence the stock price.